8 Stocks Surging on Big Volume
ImmunoGen
ImmunoGen (IMGN) is focused on the development of antibody-based anticancer therapeutics. This stock is trading up 3.6% at $14.35 in recent trading.
Today's Volume: 1.1 million
Average Volume: 816,362 Volume % Change: 125% Shares of IMGN are trending higher today after partner Roche Holding AG said its experimental breast cancer drug significantly extended the lives of patients when compared with standard therapy. From a technical perspective, IMGN is bouncing hard and gapping higher here right off its 200-day moving average of $13.63 with heavy volume. This move has briefly pushed IMGN above its 50-day moving average of $15.25. At last check, IMGN has hit an intraday high of $15.50 but subsequently pulled back to its current price at around $14.35. Traders should now look for long-biased trades in IMGN as long as it's trending above its 50-day at $15.25 with strong upside volume flows. I would consider any upside volume day that registers near or above 816,362 shares as bullish If IMGN can hold a trend above its 50-day, then this stock has a great chance of re-testing and possibly taking out its next major overhead resistance levels at $16.36 to $18.10.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
